MedTrace Logo

Clinical Trials

NCT05564390 | RECRUITING | PHASE2
2000 participants

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2024-06-18
Completion:
2029-05-15
Conditions
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
  • Acute Myeloid Leukemia Post Cytotoxic Therapy
  • Acute Myeloid Leukemia, Myelodysplasia-Related
  • Myelodysplastic Syndrome
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT05538130 | RECRUITING | PHASE1
124 participants

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2022-11-30
Completion:
2027-08-02
Conditions
  • Melanoma
  • Glioma
  • Thyroid Cancer
  • Non-Small Cell Lung Cancer
  • Malignant Neoplasms
  • Brain Neoplasms
  • Advanced or Metastatic Solid Tumors
  • HGG
  • LGG
  • Low Grade Glioma
  • High Grade Glioma
  • Differentiated Thyroid Cancer
  • NSCLC (Non-small Cell Lung Cancer)
Interventions
  • DRUG
No Results Yet
NCT05373095 | COMPLETED | NA
692 participants

Rudi Kundini, Pamoja Kundini

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2023-10-23
Completion:
2026-04-10
Conditions
  • HIV (Human Immunodeficiency Virus)
Interventions
  • BEHAVIORAL
No Results Yet
NCT05372159 | ACTIVE_NOT_RECRUITING
1000 participants

Vanderbilt Memory and Aging Project

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-14
Start Date:
2012-09-17
Completion:
2027-12-31
Conditions
  • Alzheimer Disease
  • Aging
  • Aged, 80 and Over
  • Biomarkers
  • Brain
  • Case-Control Studies
  • Cognitive Dysfunction
  • Neuropsychological Tests
Interventions
  • OTHER
No Results Yet
NCT05333458 | RECRUITING | PHASE2
27 participants

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2022-08-29
Completion:
2027-05-01
Conditions
  • Advanced Alveolar Soft Part Sarcoma
  • Advanced Soft Tissue Sarcoma
  • Metastatic Alveolar Soft Part Sarcoma
  • Refractory Alveolar Soft Part Sarcoma
  • Unresectable Alveolar Soft Part Sarcoma
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • DRUG
No Results Yet
NCT05295446 | ENROLLING_BY_INVITATION
500 participants

Functional GI Disease Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-14
Start Date:
2016-02-11
Completion:
2027-07-01
Conditions
  • Functional Gastrointestinal Disorders
No Results Yet
NCT05256225 | RECRUITING | PHASE3
360 participants

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2022-11-16
Completion:
2027-10-31
Conditions
  • Endometrial Carcinoma
  • Endometrial Clear Cell Adenocarcinoma
  • Endometrial Dedifferentiated Carcinoma
  • Endometrial Endometrioid Adenocarcinoma
  • Endometrial Mixed Cell Adenocarcinoma
  • Endometrial Serous Adenocarcinoma
  • Endometrial Undifferentiated Carcinoma
  • Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor
Interventions
  • PROCEDURE
  • DRUG
  • RADIATION
  • OTHER
No Results Yet
NCT05231122 | RECRUITING | PHASE2
80 participants

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2024-03-12
Completion:
2027-03-15
Conditions
  • Ovarian Clear Cell Adenocarcinoma
  • Platinum-Sensitive Ovarian Carcinoma
  • Recurrent Endometrial Serous Adenocarcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Fallopian Tube Endometrioid Adenocarcinoma
  • Recurrent Fallopian Tube Serous Adenocarcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Ovarian Clear Cell Adenocarcinoma
  • Recurrent Ovarian Endometrioid Adenocarcinoma
  • Recurrent Ovarian Serous Adenocarcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Recurrent Primary Peritoneal Clear Cell Adenocarcinoma
  • Recurrent Primary Peritoneal Endometrioid Adenocarcinoma
  • Recurrent Primary Peritoneal Serous Adenocarcinoma
Interventions
  • BIOLOGICAL
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page